Publications by authors named "Saschveen Singh"
Though many studies on COVID have been published to date, data on COVID-19 epidemiology, symptoms, risk factors and severity in low- and middle-income countries (LMICS), such as Afghanistan are sparse. To describe clinical characteristics, severity, and outcomes of patients hospitalized in the MSF COVID-19 treatment center (CTC) in Herat, Afghanistan and to assess risk factors associated with severe outcomes. 1113 patients were included in this observational study between June 2020 and April 2022.
View Article and Find Full Text PDFArticle Synopsis
- - Médecins Sans Frontières (MSF) provides medical care for over 7,000 snakebite cases annually in more than 70 countries, focusing on Central African Republic, South Sudan, and Ethiopia to develop specific care models for treatment.
- - A standardized treatment protocol using two types of antivenom is implemented, along with blood tests to diagnose venom-related issues; surgeries for severe wounds are also offered, all at no cost to patients.
- - MSF's successful increase in snakebite patient admissions is attributed to high-quality, free medical care and community engagement for prevention and prompt hospital transport, although it necessitates extensive resources and staff training.
Article Synopsis
- Snakebite envenoming poses a significant public health issue in countries facing humanitarian crises, though the connection between snakebite outbreaks and such crises has not been thoroughly analyzed.
- A scoping review found 41 relevant articles but none established strong epidemiological links or causality regarding snakebites during crises, despite some evidence suggesting increased incidents during conflicts and natural disasters.
- The review highlighted alarming figures from Médecins Sans Frontières, with 6469 snakebite patients treated in 2019 across 17 countries, particularly in South Sudan, Ethiopia, Central African Republic, and Yemen, and called for more population-based studies and improved snakebite treatment resources in crisis-affected regions.
Background: Few fetuses survive childbirth when the mother is positive for Ebola virus, with almost all being miscarried or stillborn, or dying shortly after birth. Before 2019, only two infants had been reported surviving past 28 days, of whom one tested positive for Ebola virus and subsequently received experimental therapies. Little is understood regarding the care of surviving neonates born to Ebola virus-positive mothers in the postnatal period and how novel anti-Ebola virus therapies might affect neonatal outcomes.
View Article and Find Full Text PDF